You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Evidence-Based Dermatology: Research Commentaries What Are the Risks of Serious Infections and Malignancies for Patients Treated With Anti-Tumor Necrosis Factor Antibodies?
Observations Psoriasis and Pustular Dermatitis Triggered by TNF- Inhibitors in Patients With Rheumatologic Conditions
Gillian C. de Gannes; Mehran Ghoreishi; Janet Pope; Anthony Russell; David Bell; Stewart Adams; Kamran Shojania; Magdalena Martinka; Jan P. Dutz
Arch Dermatol 2007; 143: 223-231.
[Abstract][Full text][PDF]
Correspondence Autoantibodies From Patients With BSLE Inducing Recruitment of Leukocytes to the Dermoepidermal Junction and Subepidermal Splits in Cryosections of Human Skin
Josep E. Herrero-González; José M. Mascaró Jr; Carmen Herrero; Amrei Dilling; Detlef Zillikens; Cassian Sitaru
Arch Dermatol 2006; 142: 1513-1516.
[Extract][Full text][PDF]
Reviews Sex Hormones and the Genesis of Autoimmunity
Correspondence Infliximab-Induced Lupus Erythematosus Tumidus in a Patient With Rheumatoid Arthritis
Stefan W. Schneider; Sonja Staender; Bernhard Schlüter; Thomas A. Luger; Gisela Bonsmann
Arch Dermatol 2006; 142: 115-116.
[Extract][Full text][PDF]
Studies No Evidence for Increased Risk of Cutaneous Squamous Cell Carcinoma in Patients With Rheumatoid Arthritis Receiving Etanercept for Up to 5 Years
Mark Lebwohl; Robin Blum; Eric Berkowitz; Dennis Kim; Ralph Zitnik; Cheri Osteen; Wayne Jack Wallis
Arch Dermatol 2005; 141: 861-864.
[Abstract][Full text][PDF]
Observations Recurrence of Alopecia Areata in a Patient Receiving Etanercept Injections